CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS)
MASH
CHOLESTASIS
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Embassy of Education CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Webcasts & Podcasts Abstract Library Committee Members
 
HCV |Abstract Library
Abstract Library
 
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
Abstract Details Back
 
 
     
 
Vertical Transmission of Hepatitis C Virus Among Women with a History of Injection Opioid Use
  
 
 

Clin Infect Dis. 2024 Apr 5:ciae177. doi: 10.1093/cid/ciae177. Online ahead of print.

 

John M Cafardi 1, Hong T Lin 2, Lana Lange 3, Lacey Kelley 4, Kelly Lemon 5, Elizabeth A Odegard 2, Heidi L Meeds 2, Jason T Blackard 2, Judith Feinberg 6
     
 

Author information

1Division of Infectious Diseases, Department of Medicine, The Christ Hospital and the Lindner Research Institute, Cincinnati, OH  USA.

2Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH  USA.

3Department of Gynecology and Obstetrics, The Christ Hospital, Cincinnati, OH  USA.

4Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, WV  USA.

5Department of Gynecology and Obstetrics, West Virginia University School of Medicine, Morgantown, WV  USA.

6Departments of Behavioral Medicine and Psychiatry & Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV  USA.

Abstract

We evaluated vertical transmission and linkage to care in women with HCV and history of injection drug use employing co-localized testing and treatment. Transmission occurred in 1 of 23 infants, with mother-infant genetic distance of 1.26%. Rates for infant testing, maternal linkage and cure were 77%, 52%, and 100%, respectively.

  
 
 
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2024 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2024 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.